Central Clinical School, Monash University, Melbourne, Victoria, Australia; Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.
Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Clin Microbiol Infect. 2021 Dec;27(12):1799-1804. doi: 10.1016/j.cmi.2021.03.033. Epub 2021 May 6.
There is limited evidence about the transmission and prevalence of oropharyngeal gonorrhoea in heterosexuals. From August 2017, Melbourne Sexual Health Centre (MSHC) began testing for oropharyngeal gonorrhoea among heterosexuals with untreated urogenital gonorrhoea. This study aims to determine the positivity of oropharyngeal gonorrhoea among heterosexuals diagnosed with urogenital gonorrhoea at MSHC between August 2017 and May 2020.
We included individuals who had oropharyngeal gonorrhoea testing within 30 days of initial testing. We reported the number and proportion of oropharyngeal gonorrhoea positivity, stratified by gender and contact of gonorrhoea. The χ test was performed to compare the oropharyngeal gonorrhoea positivity between groups.
Of 617 individuals with untreated urogenital gonorrhoea, 424 (68.7%) were tested for oropharyngeal gonorrhoea. Oropharyngeal gonorrhoea positivity was 38.9% (95%CI 34.2-43.7%, 165/424), and was higher in women than in men (115/252, 45.6% versus 50/172, 29.1%, p = 0.001). Furthermore, oropharyngeal gonorrhoea positivity was higher among individuals who were contacts of gonorrhoea cases compared to those who were not (29/44, 65.9% versus 136/380, 35.8%, p < 0.001). There was also no significant difference between women who were sex workers and those who were not (30/78, 38.5% versus 85/174, 48.9%, p = 0.126).
Our data suggest that oropharyngeal gonorrhoea infection is common among heterosexual women and heterosexual men with untreated urogenital gonorrhoea. Testing heterosexual women and heterosexual men for oropharyngeal gonorrhoea will identify a significant proportion with unrecognized oropharyngeal infections whose recommended treatment is different in some countries.
关于异性恋者中口咽淋病的传播和流行情况,证据有限。自 2017 年 8 月起,墨尔本性健康中心(MSHC)开始对未经治疗的泌尿生殖系淋病患者进行口咽淋病检测。本研究旨在确定 2017 年 8 月至 2020 年 5 月期间在 MSHC 诊断为泌尿生殖系淋病的异性恋者中口咽淋病的阳性率。
我们纳入了在初次检测后 30 天内进行口咽淋病检测的个体。我们报告了泌尿生殖系淋病患者中口咽淋病阳性率的数量和比例,按性别和淋病接触情况进行分层。采用卡方检验比较各组的口咽淋病阳性率。
在 617 例未经治疗的泌尿生殖系淋病患者中,424 例(68.7%)接受了口咽淋病检测。口咽淋病阳性率为 38.9%(95%CI 34.2-43.7%,165/424),女性高于男性(115/252,45.6%比 50/172,29.1%,p=0.001)。此外,淋病接触者的口咽淋病阳性率高于非淋病接触者(29/44,65.9%比 136/380,35.8%,p<0.001)。性工作者和非性工作者女性之间的口咽淋病阳性率也无显著差异(30/78,38.5%比 85/174,48.9%,p=0.126)。
我们的数据表明,未经治疗的泌尿生殖系淋病患者中,异性恋女性和男性的口咽淋病感染较为常见。对异性恋女性和男性进行口咽淋病检测,将发现相当一部分未经识别的口咽感染患者,在一些国家,这些患者的推荐治疗方法有所不同。